This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Susana Tchilibon: Innovator in Cannabidiol Derivatives
Introduction
Susana Tchilibon is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceutical compositions, particularly focusing on cannabidiol derivatives. Her work aims to harness the therapeutic potential of these compounds for various medical applications.
Latest Patents
Susana Tchilibon holds one patent titled "Pharmaceutical compositions comprising cannabidiol derivatives." This invention relates to the development of cannabidiol derivatives that serve as anti-inflammatory agents. The compositions exhibit a range of activities, including analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic, and anticancer properties. The patent also outlines a process for preparing these derivatives and their use in medicaments for treating human ailments.
Career Highlights
Tchilibon is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. This affiliation has allowed her to engage in cutting-edge research and development in the field of medicinal chemistry. Her innovative work has positioned her as a key figure in the exploration of cannabidiol's therapeutic benefits.
Collaborations
Throughout her career, Susana Tchilibon has collaborated with notable researchers, including Raphael Mechoulam and Ester Fride. These partnerships have enriched her research endeavors and contributed to the advancement of knowledge in the field of cannabinoid research.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile